The Swedish National Quality Register for Repetitive Transcranial Magnetic Stimulation
Acta Psychiatrica Scandinavica · 2026
DOI: 10.1111/acps.70082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Psychiatrica Scandinavica, 2026. Verfasst von S Melker Hagsäter und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Registries, Transcranial Magnetic Stimulation, Outcome Assessment, Health Care. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Repetitive transcranial magnetic stimulation (rTMS) has been demonstrated to be an effective and well tolerated treatment for depression, and it is being investigated also for other indications. This study presents the Swedish National Quality Register for rTMS (Q‐rTMS). The registry comprises epidemiological data, data from standardized rating scales, details on treatment settings, and a registry‐specific patient questionnaire.
Methods
A presentation of the Q‐rTMS including the types of data collected, the organizational structure of the register, as well as a brief overview of the volume of data accumulated between the registry's inception in 2018 and the end of 2024.
Results
As of 2024, the register contained data from a total of 3083 unique individuals and 3842 treatment series, collected from 27 different rTMS providers. The most common indication for rTMS was depression (International Classification of Diseases, Tenth Revision diagnoses (ICD‐10): F32–F34, 74.1%) followed by bipolar affective disorder (ICD‐10: F31, 14.2%). The average age was 43.2 years, and 56.5% were women. The register included matched pre‐ and post‐treatment data exceeding 60% completeness for the Montgomery–Åsberg Depression Rating Scale—Self Assessment (MADRS‐S), the Clinical Global Impression–Severity (CGI‐S), and the EuroQol five‐dimensional questionnaire (EQ‐5D‐5L).
Conclusion
The Q‐rTMS combines high coverage with longitudinal documentation of clinically relevant outcome measures and may hence contribute to population‐based real‐world effectiveness research in rTMS for depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
- Kungälv Hospital, Västra Götaland Regional Council, Kungälv, Sweden.
- Faculty of Medicine and Health, University Health Care Research Centre, Örebro University, Örebro, Sweden.
- Department of Biomedical and Clinical Sciences, Center for Social and Affective Neuroscience, Linköping University, Linköping, Sweden.
- Department of Psychiatry in Linköping, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
- Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institute, Stockholm Health Care Services, Region Stockholm, Sweden.
ORCID-Profile: S Melker Hagsäter, Fredrik Hieronymus
Zitieren
APA
Hagsäter, S. M., Nordenskjöld, A., Nordanskog, P., Lundberg, J., Ekman, C. J., Hieronymus, F., & Bodén, R. (2026). The Swedish National Quality Register for Repetitive Transcranial Magnetic Stimulation. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.70082
Vancouver
Hagsäter SM, Nordenskjöld A, Nordanskog P, Lundberg J, Ekman CJ, Hieronymus F, et al. The Swedish National Quality Register for Repetitive Transcranial Magnetic Stimulation. Acta Psychiatrica Scandinavica. 2026. doi:10.1111/acps.70082
BibTeX
@article{Hagster2026,
author = {Hagsäter, S Melker and Nordenskjöld, Axel and Nordanskog, Pia and Lundberg, Johan and Ekman, Carl Johan and Hieronymus, Fredrik and Bodén, Robert},
title = {The Swedish National Quality Register for Repetitive Transcranial Magnetic Stimulation},
journal = {Acta Psychiatrica Scandinavica},
year = {2026},
doi = {10.1111/acps.70082}
}
EUVIMED